Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
67.27
+7.52 (12.59%)
At close: Jun 26, 2026, 4:00 PM EDT
67.19
-0.08 (-0.12%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $26.69 billion as of June 26, 2026. Its market cap has increased by 148.71% in one year.
Market Cap
26.69B
Enterprise Value
20.53B
1-Year Change
148.71%
Ranking
Category
Stock Price
$67.27
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $26.69B, an increase of 336.25%. That is a compound annual growth rate of 21.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 26.69B | 131.64% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alnylam Pharmaceuticals | 39.59B |
| Revolution Medicines | 37.99B |
| Royalty Pharma | 31.59B |
| BeOne Medicines AG | 31.03B |
| Roivant Sciences | 24.46B |
| Insmed | 22.93B |
| Incyte | 22.67B |
| BioNTech SE | 22.56B |